☰
✕

Prefilled syringes market

Prefilled Syringes Market, by Material (Glass, Plastic/Polymer), by Drug Type (Biologics, Vaccines, Insulin, Anticoagulants, Flush Saline Syringes and Others), by Design (Single-chamber, Dual-chamber, and Multi-chambered), by Product Type (Staked in-needle pre-filled syringes and Needle-free pre-filled syringes), by Usability (Disposable and Reusable), by Manufacturing Method (Captive and Merchant), by End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Request Free Sample
  • Jun 2023
  • CMI162
  • 401 Pages
  • Excel & Pdf
  • Pharmaceutical

Global Prefilled Syringes Market is estimated to be valued at US$ 6.44 billion in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030). Increase in launch of products by key market players is expected to drive the market growth over forecast period. Moreover, increase in prevalence of chronic and infectious diseases is expected to drive the market growth over forecast period (2023-2030).

Analysts’ Views on Global Prefilled Syringes Market:

The prefilled syringes market's growth is expected have a positive impact over the forecast period, owing to increasing technology developments and robotic implementation in manufacturing prefilled syringes. For instance, in June 2021, Shilpa Medicare Limited, an India-based specialty generic pharmaceutical company, expanded its oncology drug production with Robotic Pilot Line. The new pilot line will help process vials, pre-filled syringes (PFS), and cartridges for injectable oncology drugs. Shilpa Medicare Limited worked with Steriline, an Italy-based provider of aseptic processing machinery and 10-year partner to Shilpa Medicare, to develop an innovative filling, stoppering, and capping system. Steriline designed a robotic line composed of a semiautomatic Robotic Nest Filling Machine (RNFM1-Lab) and a Vial Capping Machine (VCM50), both able to process the vials, prefilled syringes (PFS), and cartridges for injectable oncology drugs.

Figure 1.Global Prefilled Syringes Market Share (%), by Drug Type, 2023

Global Prefilled Syringes Market- Driver

Increasing Product Launches by Market Players

Major companies operating in the global prefilled syringes market are focused on organic growth strategies such as product launches, which is expected to drive growth of the global prefilled syringes market over the forecast period. For instance, in October 2022, Hikma Pharmaceuticals PLC., a pharmaceutical company, launched Succinylcholine Chloride Injection, in prefilled syringe (PFS) form. Succinylcholine Chloride is an important medicine used in hospitals for general anesthesia, to facilitate tracheal intubation, and to provide muscle relaxation during surgery or mechanical ventilation. The U.S. FDA-approved 100mg/5mL prefilled syringes for medication to introduced in the U.S.

Increasing Prevalence of chronic and infectious diseases

The increasing prevalence of chronic and infectious diseases such as diabetes and cancer, among others, who require care for a longer duration of time is a major factor contributing to the market growth. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases.

Figure 2. Global Prefilled Syringes Market Share (%), by Region, 2023

Global Prefilled Syringes Market- Regional Analysis

Among all regions North America region is expected to dominate the market over the forecast period. This is attributed owing to market players in the region focusing on gaining approvals and for new pre-filled safety syringes from regulatory bodies and launching new pre-filled safety syringes. For instance, on March 2, 2023, Nexus Pharmaceuticals Inc., a pharmaceutical company, received the U.S. FDA approval for single-dose prefilled syringe Emerphed (ephedrine sulfate injection). The newly approved injection is available in 25mg/5mL and 50mg/10mL strengths and is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

The Europe region is expected to second largest region over the forecast period owing to increasing number of facility expansions and investments by market players for the development of prefilled syringes. For instance, in October 2022, Recipharm, a global contract development and manufacturing organization (CDMO) had invested in a new high-speed filling line for pre-filled syringes and cartridges at its facility in Wasserburg, Germany.

Global Prefilled Syringes Market– Impact of Coronavirus (COVID-19) Pandemic

Coronavirus disease 2019 (COVID-19) is a highly contagious infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to World Health Organization (WHO) as of April 06, 2023, 762,201,169 people are affected worldwide.

For treatment of COVID-19, government with the pharmaceutical companies launched vaccines for the COVID-19. Due to the launches of vaccine, there was increase in demand for prefilled syringes, and this is expected to positively impact the growth of global prefilled syringes market over forecast period. For instance, in July 2022, Novavax, Inc., a biotechnology company that is dedicated to developing and commercializing next-generation vaccines for critical infectious illnesses, signed an agreement with its partner, SK bioscience, a global vaccine and biotechnology company, for the manufacture and supply of an Omicron variant of the Novavax COVID-19 vaccine (NVX-CoV2373), as well as the manufacture of the vaccine in prefilled syringe.

Prefilled Syringes Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 6.44 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 5.6% 2030 Value Projection: US$ 9.41 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Material: Glass, Plastic/Polymer
  • By Drug Type: Biologics (Monoclonal Antibodies, Blood Products, Others (Erythropoietin, Therapeutic proteins, among others)), Vaccines (Conjugated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Others (Virus-like particles (VLPs), Viral vector vaccines)), Insulin, Anticoagulants, Flush Saline Syringes, Others
  • By Design: Single-chamber, Dual-chamber, Multi-chambered
  • By Product Type: Staked in-needle pre-filled syringes, Needle-free pre-filled syringes
  • By Usability: Disposable, Reusable
  • By Manufacturing Method: Captive, Merchant
  • By End User: Hospital, Clinics, Ambulatory Surgical Centers, Others
Companies covered:

Gerresheimer AG,  Becton, Dickinson and Company,  West Pharmaceutical Services, Inc.,  Terumo Corporation,  Nipro Europe Group Companies,  B. Braun SE,  Sanofi,  GSK plc.,  Pfizer Inc.,  Bayer AG,  Polymedicure,  Amsino International, Inc.,  Leeford Healthcare Limited,  Torrent Pharmaceuticals Ltd.,  Regeneron Pharmaceuticals Inc.,  Ypsomed AG,  SOL-Millennium,  Stevanato Group S.p.A.
Growth Drivers:
  • Increasing product launches by key players in the market
  • Increasing prevalence of chronic diseases and infections
Restraints & Challenges:
  • Product Recalls
  • Availability of Alternated Drug Delivery Methods

Global Prefilled Syringes Market Segmentation:

The Global Prefilled Syringes Market report is segmented into material, drug type, design, product type, usability, manufacturing method, end user and region

Based on Material, the market is segmented into Glass and Plastic/Polymer. Out of which, Plastic/polymer segment is expected to dominate the prefilled syringes market during the forecast period and this is attributed due to rising demand and increasing approvals by regulatory bodies for plastic syringes.  

Based on Drug Type, the market is segmented into Biologics, Vaccines, Insulin, Anticoagulants, Flush Saline Syringes and Others. Out of which, Biologics segment is expected to dominate the market over the forecast period and this is attributed to increasing investments by key market players for establishing new facilities in order to increase the manufacturing capacity of biologics.

Based on Design, the prefilled syringes market is segmented into Single-chamber, Dual-chamber and Multi-chambered. Single-chamber segment is expected to dominate the market over the forecast period and this is attributed to increase in the number of approvals by regulatory authorities of new single-chambered type syringes.

Based on Product Type, the prefilled syringes market is segmented into Staked in-needle pre-filled syringes and Needle-free pre-filled syringes. Staked in-needle pre-filled syringes segment is expected to dominate the market over the forecast period and this is attributed to increase in the launch of safety systems for staked in-needle pre-filled syringes that can help prevent accidental needle stick injuries.

Based on Usability, the prefilled syringes market is segmented into Disposable and Reusable syringes. Disposable pre-filled syringes segment is expected to dominate the market over the forecast period and this is attributed to increase in the launch of disposable prefilled syringes by the key market players.

Based on Manufacturing Method, the prefilled syringes market is segmented into Captive and Merchant. Merchant segment is expected to dominate the market over the forecast period and this is attributed to market players outsourcing the manufacturing of their products to contract development and manufacturing organizations (CDMOs).

Based on End User, the prefilled syringes market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Others. Hospitals segment is expected to dominate the market over the forecast period and this is attributed to the development of smart concepts such as smart labels for prefilled syringes for optimizing hospital routine management.

Based on Region, Global Prefilled Syringes Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is expected to dominate the market over the forecast period and this is attributed to the increase in number of product approvals from regulatory authorities.

Among all segmentation, drug type segment has highest potential due to increasing expansions of biologics manufacturing, increasing launches of prefilled syringes for vaccinations and other factors. For instance, in September 2022, BD (Becton, Dickinson and Company), a global medical technology company, launched a next-generation glass prefilled syringe (PFS) named Effivax Glass Prefillable Syringe for administration of vaccines. Effivax glass prefillable syringe reduces risk of line stoppage, and improves the total cost of ownership, manufacturing, and supply availability.

Global Prefilled Syringes Market Cross Sectional Analysis:

In drug type segment, biologics segment is dominant in North America region due to increasing number of product launches or approvals containing monoclonal antibodies. For instance, in April 2021, Novartis, a pharmaceutical company, received the U.S. FDA approval for Xolair prefilled syringe for self-injection. Xolair contains omalizumab as active pharmaceutical ingredient and is indicated for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU), and nasal polyps.

In material segment, Plastic/ Polymer held as a dominant segment in Asia Pacific region due to the increasing launches by medical device companies in the region. For instance, in May 2022, Terumo Pharmaceutical Solutions (TPS), a pharmaceutical and medical device manufacturer based in Japan, launched a prefillable polymer syringe named PLAJEX for low-dose applications such as ophthalmic drugs. This is a Luer Lock Silicone oil-free pre-fillable syringe, and is used for lowdose Pre-Filled Syringe (PFS) products, which makes it suitable for high-value drug applications such as intravitreal injection.

Global Prefilled Syringes Market: Key Developments

For instance, on January 4, 2023, Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, announced that it had launched Naloxone Hydrochloride Injection, USP, 2mg/2mL, in prefilled syringe (PFS) form in the U.S. It is used for the emergency treatment of a known or suspected opioid overdose.

For instance, Clemson University, a public research institution, and Nephron Pharmaceuticals Corporation, a privately held company, developed a benchtop robot in March 2021 that can fill, cap, and seal sterile prefilled syringes, which can reduce costs by preventing drug overfill and minimizing contamination. Filling syringes in the absence of a robot is a highly regulated process that needs to be undertaken by specialized technicians under ISO-certified clean rooms. The robot is expected to help in addressing the shortage of prefilled syringes in hospitals and healthcare facilities.

In November 2022, Tjoapack, a contract packaging organization, invested in a new packaging line for pre-filled syringes (PFS) and vials at its production facilities in both Europe and the U.S. The PFS line can pack pre-filled syringes of 1 to 5ml, with or without safety devices, and other customer-specific components can also be added.

In April 2021, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) had approved the company’s supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection across all approved U.S. indications. Xolair is the only U.S. FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU), and nasal polyps.

Global Prefilled Syringes Market: Restraint

Product Recalls

Several syringes have been recalled owing to defects in the container or plunger design, which makes the filling of drugs in them inefficient. The recent recalls of prefilled and pre-fillable syringes around the world are expected to significantly hamper the growth of the market over the forecast period.

For instance, in June 2022, Nephron Pharmaceuticals, a company that manufactures generic respiratory medications, issued a voluntary recall of some of its pre-filled syringe products due to concerns over the lack of assurance of sterility. The manufacturer indicated that the product recall was issued out of an abundance of caution and that there was no impact on patient safety.

To overcome the restraint, market players should focus on developing more safe and efficient devices adhering to all regulations and avoiding any contamination.

Availability of Alternate Drug Delivery Methods

Novel drug delivery systems involve creative formulations, new technology, and novel approaches for safely delivering pharmaceutical drugs into the body as needed to produce their intended pharmacological effects.

For instance, in 2021, Jabil Healthcare, a manufacturing services company, launched a new reusable autoinjector platform called Qfinity, a spring-driven, reusable device for use with a variety of drugs, including larger volume, higher viscosity medicines. The reusable injector operates with disposable cassettes in 1- and 2.25-ml sizes and a viscosity target of 30cP.

Market players should focus on strategies such as technology advancement of prefilled syringes, which would shift the customers to adopt prefilled syringes as the drug delivery methods instad of any alternatives, thus driving the market growth over forecast period

Global Prefilled Syringes Market: Key Players

Major players operating in the global prefilled syringes market include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc.,   Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.

Definition: A prefilled syringe is a single-dose container of medication or a vaccination, to which the manufacturer has attached a needle. Pre-filled syringes give improved dosage accuracy, require fewer steps for injection, and pose less danger of harm and cross-contamination. Pre-filled syringes are frequently taken into consideration as early as Phase II in the drug development process and are now a generally acknowledged component of the medication life-cycle. Prefilled syringe cartridges are made to fit into particular syringes that are used to give different liquid drugs. These replace traditional syringes, which healthcare professionals must manually fill before each dose is given. Prefilled syringe cartridges provide the benefits of simplicity, low cost, precision, sterility, and safety.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Material
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Design
      • Market Snapshot, By Product Type
      • Market Snapshot, By Usability
      • Market Snapshot, By Manufacturing Method
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Attractiveness Analysis
      • Market Opportunities
    • Product Launches
    • Merger, Acquisition, Collaborations
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • Technology Landscape
    • Service Cost Analysis
  4. Global Prefilled Syringes Market– COVID-19 Impact Analysis
    •  Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. Global Prefilled Syringes Market, By Material, 2018–2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Glass
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Plastic/Polymer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  6. Global Prefilled Syringes Market, By Drug Type, 2018–2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Biologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
        • Monoclonal Antibodies
        • Blood Products
        • Others (Erythropoietin, Therapeutic proteins, among others)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
        • Conjugated Vaccines
        • Live Attenuated Vaccines
        • Recombinant Vaccines
        • Others (Virus-like particles (VLPs), Viral vector vaccines)
    • Insulin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Anticoagulants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Flush Saline Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  7. Global Prefilled Syringes Market, By Design, 2018 – 2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Single-chamber
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Dual-chamber
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Multi-chambered
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  8. Global Prefilled Syringes Market, By Product Type, 2018 – 2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Staked in-needle pre-filled syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Needle-free pre-filled syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  9. Global Prefilled Syringes Market, By Usability, 2018 – 2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Disposable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Reusable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  10. Global Prefilled Syringes Market, By Manufacturing Method, 2018 – 2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Captive
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Merchant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  11. Global Prefilled Syringes Market, By End User, 2018 – 2030, (US$ Billion
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segments Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
  12. Global Prefilled Syringes Market, By Region, 2018 – 2030, (US$ Billion)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2030
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 – 2030, (US$ Billion)
        • North Africa
        • Central Africa
        • South Africa
  13. Competitive Landscape
    • Gerresheimer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Becton, Dickinson and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • West Pharmaceutical Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nipro Europe Group Companies
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • B.Braun SE
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc.
      • Company Highlights
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Polymedicure
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amsino International, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Leeford Healthcare Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
      • Torrent Pharmaceuticals Ltd.
    • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Regeneron Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ypsomed AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SOL-Millennium
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stevanato Group S.p.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  14. Section
    • Research Methodology
    • About Us

*Browse 70 market data tables and 51 figures on “Prefilled Syringes Market” - Global forecast to 2030

Detailed Segmentation:

  • Global Prefilled Syringes Market, By Material:
    • Glass
    • Plastic/Polymer
  • Global Prefilled Syringes Market, By Drug Type:
    • Biologics
      • Monoclonal Antibodies
      • Blood Products
      • Others (Erythropoietin, Therapeutic proteins, among others)
    • Vaccines
      • Conjugated Vaccines
      • Live Attenuated Vaccines
      • Recombinant Vaccines
      • Others (Virus-like particles (VLPs), Viral vector vaccines)
    • Insulin
    • Anticoagulants
    • Flush Saline Syringes
    • Others
  • Global Prefilled Syringes Market, By Design:
    • Single-chamber
    • Dual-chamber
    • Multi-chambered
  • Global Prefilled Syringes Market, By Product Type:
    • Staked in-needle pre-filled syringes
    • Needle-free pre-filled syringes
  • Global Prefilled Syringes Market, By Usability:
    • Disposable
    • Reusable
  • Global Prefilled Syringes Market, By Manufacturing Method:
    • Captive
    • Merchant
  • Global Prefilled Syringes Market, By End User:
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Prefilled Syringes Market, By Region:
    • North America
      • By Material:
        • Glass
        • Plastic/Polymer
      • By Drug Type:
        • Biologics
          • Monoclonal Antibodies
          • Blood Products
          • Others (Erythropoietin, Therapeutic proteins, among others)
        • Vaccines
          • Conjugated Vaccines
          • Live Attenuated Vaccines
          • Recombinant Vaccines
          • Others (Virus-like particles (VLPs), Viral vector vaccines)
        • Insulin
        • Anticoagulants
        • Flush Saline Syringes
        • Others
      • By Design:
        • Single-chamber
        • Dual-chamber
        • Multi-chambered
      • By Product Type:
        • Staked in-needle pre-filled syringes
        • Needle-free pre-filled syringes
      • By Usability:
        • Disposable
        • Reusable
      • By Manufacturing Method:
        • Captive
        • Merchant
      • By End User:
        • Hospital
        • Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Material:
        • Glass
        • Plastic/Polymer
      • By Drug Type:
        • Biologics
          • Monoclonal Antibodies
          • Blood Products
          • Others (Erythropoietin, Therapeutic proteins, among others)
        • Vaccines
          • Conjugated Vaccines
          • Live Attenuated Vaccines
          • Recombinant Vaccines
          • Others (Virus-like particles (VLPs), Viral vector vaccines)
        • Insulin
        • Anticoagulants
        • Flush Saline Syringes
        • Others
      • By Design:
        • Single-chamber
        • Dual-chamber
        • Multi-chambered
      • By Product Type:
        • Staked in-needle pre-filled syringes
        • Needle-free pre-filled syringes
      • By Usability:
        • Disposable
        • Reusable
      • By Manufacturing Method:
        • Captive
        • Merchant
      • By End User:
        • Hospital
        • Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Material:
        • Glass
        • Plastic/Polymer
      • By Drug Type:
        • Biologics
          • Monoclonal Antibodies
          • Blood Products
          • Others (Erythropoietin, Therapeutic proteins, among others)
        • Vaccines
          • Conjugated Vaccines
          • Live Attenuated Vaccines
          • Recombinant Vaccines
          • Others (Virus-like particles (VLPs), Viral vector vaccines)
        • Insulin
        • Anticoagulants
        • Flush Saline Syringes
        • Others
      • By Design:
        • Single-chamber
        • Dual-chamber
        • Multi-chambered
      • By Product Type:
        • Staked in-needle pre-filled syringes
        • Needle-free pre-filled syringes
      • By Usability:
        • Disposable
        • Reusable
      • By Manufacturing Method:
        • Captive
        • Merchant
      • By End User:
        • Hospital
        • Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Material:
        • Glass
        • Plastic/Polymer
      • By Drug Type:
        • Biologics
          • Monoclonal Antibodies
          • Blood Products
          • Others (Erythropoietin, Therapeutic proteins, among others)
        • Vaccines
          • Conjugated Vaccines
          • Live Attenuated Vaccines
          • Recombinant Vaccines
          • Others (Virus-like particles (VLPs), Viral vector vaccines)
        • Insulin
        • Anticoagulants
        • Flush Saline Syringes
        • Others
      • By Design:
        • Single-chamber
        • Dual-chamber
        • Multi-chambered
      • By Product Type:
        • Staked in-needle pre-filled syringes
        • Needle-free pre-filled syringes
      • By Usability:
        • Disposable
        • Reusable
      • By Manufacturing Method:
        • Captive
        • Merchant
      • By End User:
        • Hospital
        • Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Material:
        • Glass
        • Plastic/Polymer
      • By Drug Type:
        • Biologics
          • Monoclonal Antibodies
          • Blood Products
          • Others (Erythropoietin, Therapeutic proteins, among others)
        • Vaccines
          • Conjugated Vaccines
          • Live Attenuated Vaccines
          • Recombinant Vaccines
          • Others (Virus-like particles (VLPs), Viral vector vaccines)
        • Insulin
        • Anticoagulants
        • Flush Saline Syringes
        • Others
      • By Design:
        • Single-chamber
        • Dual-chamber
        • Multi-chambered
      • By Product Type:
        • Staked in-needle pre-filled syringes
        • Needle-free pre-filled syringes
      • By Usability:
        • Disposable
        • Reusable
      • By Manufacturing Method:
        • Captive
        • Merchant
      • By End User:
        • Hospital
        • Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Material:
        • Glass
        • Plastic/Polymer
      • By Drug Type:
        • Biologics
          • Monoclonal Antibodies
          • Blood Products
          • Others (Erythropoietin, Therapeutic proteins, among others)
        • Vaccines
          • Conjugated Vaccines
          • Live Attenuated Vaccines
          • Recombinant Vaccines
          • Others (Virus-like particles (VLPs), Viral vector vaccines)
        • Insulin
        • Anticoagulants
        • Flush Saline Syringes
        • Others
      • By Design:
        • Single-chamber
        • Dual-chamber
        • Multi-chambered
      • By Product Type:
        • Staked in-needle pre-filled syringes
        • Needle-free pre-filled syringes
      • By Usability:
        • Disposable
        • Reusable
      • By Manufacturing Method:
        • Captive
        • Merchant
      • By End User:
        • Hospital
        • Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the Global Prefilled Syringes Market during the forecast period (2023-2030)?

The Global Prefilled Syringes Market is estimated to be valued at US$ 6.44 billion in 2023 and is expected to exhibit a CAGR of 5.6% between 2023 and 2030.

What are the major factors driving the Market growth

The increasing prevalence of chronic diseases and infections and increasing launches of solutions and facility expansion by key players in the market are expected to drive the Market growth.

Which is the leading application segment in the Market?

Vaccine Production is the leading application segment in the Market.

What are the key factors hampering growth of the Market?

The major factors that can hamper growth of the Market include the technical and operational challenges during the synthesis and storage of mRNA therapeutics.

• Which are the major players operating in the Global Prefilled Syringes Market?

Major players operating in the Global Prefilled Syringes Market include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Buy Now with Special Discount
Customize Now